| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000259212.1 |
BAY 61-3606 |
Bladder urothelial carcinoma |
0.015251715 |
Resistant |
| ENSG00000259212.1 |
BAY 61-3606 |
Esophageal cancer |
0.037313032 |
Resistant |
| ENSG00000259212.1 |
BAY 61-3606 |
Lung squamous cell carcinoma |
0.028095428 |
Resistant |
| ENSG00000259212.1 |
BAY 61-3606 |
Colon adenocarcinoma |
0.039103471 |
Sensitive |
